Biotechs/Pharma Stocks Are Ripping Higher Weds Following IPAB Ruling

anonymous

Guest
Biotechs Are Ripping Following IPAB Ruling
by Jayson Derrick2 hours ago Wed, 22 Jun 2016
http://m.benzinga.com/stock/ACAD
http://m.benzinga.com/stock/BIB

  • Biotech stocks spiked higher on Wednesday after the U.S. government said that Medicare will be exhausted in 2028, two years sooner than projected last year.

In addition, the U.S. government said that a cost-cutting mechanism known as the Independent Payment Advisory Board (IPAB) is projected to be triggered in 2017.

According to Bloomberg, investors have been "nervously" awaiting on news for the IPAB determination on fears it could have been triggered in 2016 and set in motion reductions in Medicare payments to biotech and pharmaceutical companies.

Biotech Stocks Surging
The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) was trading higher by nearly 3 percent, while the SPDR S&P Biotech (ETF) (NYSE: XBI) was trading higher by nearly 2 percent.

The 2x leveraged-ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ: BIB) gained more than 5 percent.
 


















Yes I am a sales rep also and know EXACTLY what you an other employees want to discuss but can't until the announcement shortly. Now I bet the stock twit knit wits are dying to know about this. Just going to have to wait. HeHeHeHe
 




































Reps' stock options! Mistreatment because we can't do anything with them. It seemed we were getting something as a bonus. I thought we had shares. I wish when they were given it was clear. A lot of good they do at this price anyway.

Welcome to Pharma. Stop complaining and start call planning. Be thankful that you have a job. If the company were kicking ass, then the stock options would be a huge bonus. It's no different here than any other company that offers stock options.